Amphastar Pharmaceuticals (AMPH) Goodwill (2013 - 2026)

Amphastar Pharmaceuticals has reported Goodwill for 14 years, with the latest figure at $3.3 million in Q2 2026.

• On a quarterly basis, Goodwill fell 2.53% year-over-year to $3.3 million in Q2 2026; TTM through Jun 2026 was $3.3 million, a 2.53% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, up 11.58% from the prior year.
• Goodwill was $3.3 million for Q2 2026 at Amphastar Pharmaceuticals, down from $3.3 million in the prior quarter.
• The five-year high for Goodwill was $3.4 million in Q3 2025, with the low at $2.9 million in Q3 2022.
• Average Goodwill over 5 years is $3.2 million, with a median of $3.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Goodwill slipped 20.47% in 2022, then rose 11.58% in 2025.
• Over 5 years, Goodwill stood at $3.1 million in 2022, then grew by 2.88% to $3.2 million in 2023, then fell by 5.19% to $3.0 million in 2024, then increased by 11.58% to $3.4 million in 2025, then declined by 2.67% to $3.3 million in 2026.
• The last three Goodwill figures came in at $3.3 million (Q2 2026), $3.3 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.